BRIEF-Seneca Biopharma Says On March 17, Terminated Kenneth Carter,Chairman, Dane Saglio,CFO, Matthew Kalnik,COO And Co's Senior VP Of R&D Without Cause

Reuters
Mar 18, 2021

March 18 (Reuters) - Seneca Biopharma Inc :

* SENECA BIOPHARMA-ON MARCH 17, TERMINATED KENNETH CARTER,CHAIRMAN, DANE SAGLIO,CFO, MATTHEW KALNIK,COO, CO'S SENIOR VICE PRESIDENT OF RESEARCH AND DEVELOPMENT WITHOUT CAUSE

Source text - Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10